Table 2.

HR for mortality associated with initiation of allopurinol in the propensity score matched cohorts

	Allopurinol initiators	Non-initiators	HR (95% CI)
Deaths (N)
Hyperuricaemic cohorts	(N=5927)	(N=5927)
Total follow-up	654	718	0.89 (0.80 to 0.99)
1 year follow-up	183	233	0.77 (0.63 to0.94)
2-year follow-up	325	395	0.79 (0.68 to 0.93)
3year follow-up	439	521	0.82 (0.72 to 0.94)
Gout cohorts	(N=4795)	(N=4795)
Total follow-up	483	556	0.81 (0.70 to 0.92)
1 year follow-up	127	169	0.75 (0.59 to 0.94)
2-year follow-up	229	288	0.76 (0.63 to 0.91)
3 year follow-up	312	388	0.77 (0.66 to 0.97)